Surgical site infection (SSI) is the most common complication after surgery and represents a substantial global healthcare burden. Planning on how best to reduce SSI at an international level has been hampered by a paucity of data, particularly from countries with a low or intermediate Human Development Index (HDI) . To address this knowledge deficit, the GlobalSurg Collaborative — a body representing practicing surgeons around the world — conducted a prospective cohort study of SSI after gastrointestinal surgery in 343 hospitals worldwide. SSI incidence varied by country HDI, with 23.2% of patients in low-HDI settings experiencing an SSI versus 9.4% of patients in high-HDI settings. For cases in which a microbiology culture result was available, SSIs resistant to the prophylactic antibiotic used were found in 35.9% of patients in low-HDI countries, compared with only 16.6% of patients in high-HDI countries.
GlobalSurg Collaborative. Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(18)30101-4 (2018)
About this article
Cite this article
Thomas, H. Describing the global burden of infection after gastrointestinal surgery. Nat Rev Gastroenterol Hepatol 15, 190 (2018). https://doi.org/10.1038/nrgastro.2018.22